T Ohnuma

2.4k citations
48 papers · 2k · 1 hit paper · h-index 19

Impact in

    • Nanoparticle-Based Drug Delivery
  • Oncology top 5%
    • Cancer Treatment and Pharmacology
    • Drug Transport and Resistance Mechanisms

Papers in

    • Cancer Treatment and Pharmacology 8
    • Drug Transport and Resistance Mechanisms 6
    • Cancer Cells and Metastasis 3
    • Colorectal Cancer Treatments and Studies 3
    • Cancer therapeutics and mechanisms 15

T Ohnuma

48 papers receiving 1.9k citations

T Ohnuma's Hit Papers

Hypersensitivity reactions from taxol. 1990 · 1k citations
1k0+12+24Years since publication2505007501k

Peers

T Ohnuma
Comparison fields: 5 of 81
  • Biomaterials 428
  • Oncology 633
  • Pharmaceutical Science 114
  • Drug Discovery 4
  • Pharmacology 155
Replace Julie A. Ellerhorst with:
Julie A. Ellerhorst United States
Patricia Vrignaud France
Benjamin Winograd Netherlands
Jinee D. Rizzo United States
William J. Slichenmyer United States
John Randall Eckardt United States
Hans R. Hendriks Netherlands
Lucia Viganò Italy
Xiang Ling United States
Rami Ben‐Yosef Israel
T Ohnuma relative to Julie A. Ellerhorst United States Julie A. Ellerhorst's profile →
Citations per field
00.5×2×3×4.0×
Julie A. Ellerhorst · 1×
Citations per year

Countries citing papers authored by T Ohnuma

Since Specialization
Citations

This map shows the geographic impact of T Ohnuma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by T Ohnuma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites T Ohnuma more than expected).

Fields of papers citing papers by T Ohnuma

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by T Ohnuma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by T Ohnuma. The network helps show where T Ohnuma may publish in the future.

Co-authors

The 25 scholars most cited alongside T Ohnuma, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with T Ohnuma Line = papers co-authored together T Ohnuma links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 48 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Hypersensitivity reactions from taxol.
Hit paper breakdown →
19901022
2
Reversal of drug sensitivity in multidrug-resistant tumor cells by an MDR1 (PGY1) ribozyme.
199492
3 197387
4
Effects of vincristine in combination with methotrexate and other antitumor agents in human acute lymphoblastic leukemia cells in culture.
198880
5 198175
6 198555
7
Multidrug resistance in a human leukemic cell line selected for resistance to trimetrexate.
198945
8 199442
9 198640
10 198035
11 197934
12
Protein kinase C activity and multidrug resistance in MOLT-3 human lymphoblastic leukemia cells resistant to trimetrexate.
199130
13 199826
14 199926
15
Phase I study of indicine N-oxide in patients with advanced cancer.
198225
16 200823
17
Hepatic catalase activity in advanced human cancer.
196621
18
Initial clinical study with N-(phosphonacetyl)-L-aspartic acid (PALA) in patients with advanced cancer.
198120
19 198820
20 198518

About T Ohnuma

T Ohnuma is a scholar working on Oncology, Molecular Biology, Hematology, Immunology and Public Health, Environmental and Occupational Health, having authored 48 papers that have together received 2k indexed citations. Recurring topics across this work include Cancer therapeutics and mechanisms (15 papers), Cancer Treatment and Pharmacology (8 papers), Drug Transport and Resistance Mechanisms (6 papers), Acute Lymphoblastic Leukemia research (6 papers), Acute Myeloid Leukemia Research (4 papers), Cancer Cells and Metastasis (3 papers), Colorectal Cancer Treatments and Studies (3 papers) and T-cell and Retrovirus Studies (3 papers). The work is most often cited by research in Biomaterials (428 citations), Oncology (633 citations), Pharmaceutical Science (114 citations), Drug Discovery (4 citations) and Pharmacology (155 citations). T Ohnuma has collaborated with scholars based in United States, Japan and France. Frequent co-authors include R B Weiss, D L Trump, Richard J. Gralla, Peter H. Wiernik, Daniel D. Von Hoff, David A. Van Echo, Ross C. Donehower, Bryan Leyland-Jones, James R. Baker, Jr. and J F Holland. Their work appears in journals such as British Journal of Cancer, Blood, Recent results in cancer research, Journal of Clinical Oncology and Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact